Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information


EU orphan designation number: EU/3/11/881   
Active ingredient: Acadesine
Indication: Treatment of multiple myeloma
Sponsor: Advancell - Advanced In Vitro Cell Technologies S.A.
Via Augusta 59, 3rd floor, door 313, 08006 Barcelona, España

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
9/08/2011 Orphan designation EMA/OD/017/11 (2011)5806 of 5/08/2011
5/07/2013 Change of name and/or address of sponsor